ANGIOTECH PHARMACEUTICALS INC
Healthcare · Surgical & Medical Instruments & Apparatus · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY12 | FY11 | |
|---|---|---|
| Revenue | $243.8M | $153.0M |
| Operating income | $26.8M | −$51.5M |
| Net income | — | — |
| Total assets | $608.4M | $608.1M |
| Total liabilities | — | — |
| Equity | $140.7M | $202.9M |
| EPS (diluted) | — | — |
| Shares out. | 12.6M | 12.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2012- Operating margin
- 11.0%
- Net margin
- —
- Return on equity
- —
- Return on assets
- —
- Return on capital (ROCE)
- 5.4%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $11.20
- Revenue growth (YoY)
- 59.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 11, 2011
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Highland Crusader Offshore Partners, L.P.10% owner | Jun 21, 2012 | Sell | 1.1M | $15.43 |
| Hunter William LOfficer — CEO & President | May 12, 2011 | J | 435,356 | $0.17 |
| Dent Jay BernardOfficer — SVP, Finance | Aug 13, 2009 | J | 6,000 | $1.94 |
| Cunliffe SeanOfficer — SVP, Sales & Marketing | Sep 8, 2009 | J | 70,700 | — |
| Mcmasters DavidOfficer — SVP, Legal | Mar 31, 2008 | J | 2,000 | — |
| Neske TammyOfficer — SVP, Human Resources | Aug 14, 2009 | J | 3,000 | $1.91 |
| Gross Jeffrey MOfficer — SVP, Research & Development | Mar 26, 2010 | J | 9,000 | $1.11 |
| Bailey K ThomasOfficer — Chief Financial Officer | May 12, 2011 | J | 15,000 | $1.64 |
| Gross Jeffrey MOfficer — SVP, Research & Development | Mar 26, 2010 | Buy | 9,000 | $1.11 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Results of operationsMar 28, 2013
- Entered a material agreement · Other material eventMar 26, 2013
- Debt acceleration / triggering event · Other material eventMar 19, 2013
- Director / officer changeNov 14, 2012
- Results of operationsNov 14, 2012
- Debt acceleration / triggering event · Other material eventSep 20, 2012
- Entered a material agreement · New financial obligation · Modified shareholder rights · Other material eventAug 16, 2012
- Results of operationsAug 14, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.